<img src="img/YSM_Shield_trans.gif" height="113px" 
style="background:transparent;border:none;box-shadow:none" />&nbsp;&nbsp;
<img src="img/YNHH_logo.gif" width="650px"
style="background:transparent;border:none;box-shadow:none" /><br /><br />
# VQ Protocol Review

David Karimeddini, MD

August 22, 2013


![vqscan](img/vq_scan.jpg)  
![cta](img/cta_pe.jpg)



## SNM Practice Guidelines 4.0

* version 1.0 - 1996
* version 2.0 - 1999
* version 3.0 - 2004
* version 4.0 - 2011


## Background of the Guidelines
  
<ul>
  <li class="fragment">
    Help advance the science of nuclear medicine
  </li>
  <li class="fragment">
    Improve the quality of service to patients
  </li>
  <li class="fragment">
    Reviewed/renewed every 5 years (or sooner)
  </li>
  <li class="fragment">
    Educational tool
  </li>
  <li class="fragment">
    Not inflexible rules/requirements of practice
  </li>
  <li class="fragment">
    Not intended to establish a legal **standard of care**
  </li>
  <br /> 
  <li class="fragment">
    Practice of medicine involves **"art"**, not only **science**.  
  </li>
</ul>


## Background of the Guidelines
  
Safe and effective care:  
"Reasonable course of action based on..."
<ol>
  <li class="fragment">
    Knowledge
  </li>
  <li class="fragment">
    Available Resources
  </li>
  <li class="fragment">
    Needs of the Patient
  </li>
</ol>
 


## Purpose of the Guidelines

Assist practitioners in:
<ol>
  <li class="fragment">
    Recommending
  </li>
  <li class="fragment">
    Performing
  </li>
  <li class="fragment">
    Interpreting
  </li>
  <li class="fragment">
    Reporting
  </li>
</ol>


## Common Clinical Indications

1. Acute pulmonary embolism likelihood
1. Chronic PE / resolution of acute PE
1. Quantify pulmonary function
1. Congenital heart / lung disease (shunts, stenoses, fistulae)
1. Bronchopleural fistula
1. Cystic fibrosis
1. Pulmonary hypertension



## Pertinent Clinical History

* Pregnant / Nursing
* Pretest probability (Wells score)
* D-dimer
* History of DVT / PE
* Prior imaging (CXR, V/Q scan)
* Anticoagulation / Thrombolytics
* Deep vein ultrasonography



## Prerequisites (preferably)

* PA / Lateral CXR (recent)
* CT chest can substitute

![cxr](img/cxr.png)



## Radiopharmaceuticals

### Ventilation

* Tc-99m-DTPA aerosol
* Tc-99m-sulfur colloid aerosol
* Tc-99m-carbon suspension (Technegas)
* Kr-81m
* Xe-133


### Ventilation

* Tc-99m-DTPA aerosol / sulfur colloid aerosol
  * DTPA most commonly used
  * 25-35 mCi in nebulizer
  * 0.5-1.0 mCi inhaled
* Tc-99m-carbon suspension (Technegas)
  * Not approved for use in USA
  * Preferable agent, expecially in COPD


### Ventilation

* Kr-81m continuous inhalation
  * Not available in the USA
* Xe-133
  * 5-20 mCi
  * Appropriate exhaust in room
  * Posterior images only (sometimes obliques)



## Radiopharmaceuticals

### Perfusion

* Tc-99m-MAA



## References

[Return to beginning](#/1)
